Gikakis Nicolas 4

What Happened

• Nicolas Gikakis, a director of Aethlon Medical (AEMD), had 178 shares forfeited on March 31, 2026 to cover tax withholding related to the conversion of vested restricted stock units (RSUs). The forfeited shares were valued at $2.19 each, totaling about $390.
• Footnote disclosure shows an aggregate 268 vested RSUs converted into shares and 178 of those shares were withheld for taxes, which implies Gikakis received 90 shares net (268 converted − 178 withheld).

Key Details

• Transaction date: 2026-03-31; filing date: 2026-04-01 (filed timely).
• Transaction type/code: Tax withholding on RSU conversion (code F); not an open-market sale or purchase.
• Price used for withholding: $2.19 per share; 178 shares forfeited = ~$390.
• Related disclosure: These RSUs were part of a grant reported in the Form 4 filed April 25, 2025.
• Shares owned after the transaction: not stated explicitly in this filing (net received from this conversion = 90 shares based on the footnote math).

Context

• This is a routine tax-withholding action tied to vested RSUs (often called a "share withholding" or cashless withholding). It does not represent an open-market sale and generally does not signal a change in the insider’s view of the company.
• Such transactions are common when equity awards vest and taxes are due; they reduce outstanding shares held by the insider but are administrative rather than opportunistic trades.